Page last updated: 2024-10-31

nocodazole and Ebola Hemorrhagic Fever

nocodazole has been researched along with Ebola Hemorrhagic Fever in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nelson, EA1
Dyall, J1
Hoenen, T1
Barnes, AB1
Zhou, H1
Liang, JY1
Michelotti, J1
Dewey, WH1
DeWald, LE1
Bennett, RS1
Morris, PJ1
Guha, R1
Klumpp-Thomas, C1
McKnight, C1
Chen, YC1
Xu, X1
Wang, A1
Hughes, E1
Martin, S1
Thomas, C1
Jahrling, PB1
Hensley, LE1
Olinger, GG1
White, JM1
Kota, KP1
Benko, JG1
Mudhasani, R1
Retterer, C1
Tran, JP1
Bavari, S1
Panchal, RG1

Other Studies

2 other studies available for nocodazole and Ebola Hemorrhagic Fever

ArticleYear
The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection.
    PLoS neglected tropical diseases, 2017, Volume: 11, Issue:4

    Topics: Animals; Antiviral Agents; Biological Transport; Cell Line; Chlorocebus aethiops; Ebolavirus; Hemorr

2017
High content image based analysis identifies cell cycle inhibitors as regulators of Ebola virus infection.
    Viruses, 2012, Sep-25, Volume: 4, Issue:10

    Topics: Aphidicolin; Benzimidazoles; Cell Cycle; Cell Cycle Checkpoints; Cell Line; Cell Nucleus; Cell Proli

2012